Radiopharmaceutical Trials
Partnering with sponsors to advance radiopharmaceutical development, with extensive experience in delivering complex radiopharmaceutical clinical trials
Radiopharmaceutical development integrates expertise across nuclear physics, radiochemistry, clinical science, and precision medicine. At Aixial Group, we apply this multidisciplinary approach to support radiotherapeutic, diagnostic, and theranostic programmes across all phases of clinical development. We partner with sponsors to advance radiotherapeutic, radiodiagnostic, and theranostic programmes from early discovery through the entire clinical development journey.
Radiopharmaceutical clinical trial expertise
- Patient safety: Tailored monitoring and radiation exposure management
- Global site network: Leading nuclear medicine centres across APAC, Europe, and the Americas
- Isotope logistics: Supply-chain management and coordination of short and long half-life compounds
- Site readiness & training: Radiation safety, protocol compliance, and specialised staff
- Regulatory expertise: Multi-region approvals, radiation permits, and ethics submissions
- Quality & compliance: GMP and GCP standards across manufacture and clinical trials
- Sponsor collaboration: Integrated project management, transparent reporting, and risk mitigation
- Cross-modal capability: Therapeutic, diagnostic, and theranostic trials with alpha- and beta-emitting isotopes.
- Global execution: Multi-region coordination and isotope delivery for seamless international studies.
The Aixial team understand the complexities of radiopharmaceutical clinical trials. By combining scientific leadership, operational precision, and global reach, Aixial Group ensures your trials are executed safely, efficiently, and successfully.
Evidence of outcomes — proven track record
Our extensive experience is reflected in a growing global portfolio of radiopharmaceutical trials, across all modalities, in various indications, and including early-phase through later-phase studies:
- 45+ radiopharmaceutical trials delivered across multiple indications and isotopes
- Global execution across APAC, Europe, and the Americas, leveraging deep site networks in leading nuclear medicine centres.
- Experience managing complex studies involving distinct isotopes — including 225Ac, 11C, 18F, 64Cu, 131I, 177Lu, and others.
Scientific-led trial planning and execution
We support sponsors in every critical phase of radiopharmaceutical programmes, including:
- Protocol strategy and design tailored to modality (therapeutic, diagnostic, theranostic)
- Isotope-specific operational planning, including half-life, production and delivery logistics
- Regulatory strategy aligned with regional requirements for radiation and nuclear medicine studies
- Site qualification and activation, leveraging established relationships with highly specialised nuclear medicine and imaging centres
- Integrated data and imaging endpoints, enhancing biomarker interpretation and clinical decision workflows
Our teams align clinical, scientific, and operational functions into an integrated delivery approach, reducing risk and accelerating timelines for complex radiopharmaceutical trials.
Why Sponsors Choose Aixial Group
Focused cross-modal radiopharmaceutical expertise
Hands-on teams experienced in radiation science, imaging biomarkers, and nuclear medicine
Proven ability to navigate supply chain and isotope logistics
Global delivery with consistent quality, compliance, and risk management
Whether you’re advancing a novel radiotherapeutic, validating a new diagnostic tracer, or building a matched theranostic programme, Aixial Group provides the scientific leadership, operational excellence, and global reach to drive your radiopharmaceutical development forward.
How can we support your next project?
Contact us to discuss your radiopharmaceutical programme or request a feasibility assessment to support your next study.
Aixial Experience with Isotopes: Half-Life and Emission Type (α/β)
| Isotope | Half Life | α or β |
| 212Pb | 10.6hrs | β |
| 211At | 7.2hrs | α |
| 89Ac | 21.6yrs | α |
| 225Ac | 9.9 days | α |
| 11C | 20.4min | β |
| 14C | 5.7k yrs | β |
| 64Cu | 12.7hrs | β |
| 18F | 1.82hrs | β |
| 58Fe | Stable | n/a |
| 68Ga | 1.1hrs | β |
| 177Lu | 6.7days | β |
| 131I | 8 days | β |
Aixial Experience Across Clinical Indications and Modalities
Other ways we support you
Helping you succeed in your project